CDKN1A and Alzheimer disease: In the brains of patients with AD, Aβ-associated OPCs expressing Olig2 and ng2 show increased expression of p21/CDKN1A and p16/INK4/CDKN2A and increased age-related β-galactosidase activity, exhibiting an ageing-like phenotype [154].